BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mordente A, Meucci E, Martorana GE, Silvestrini A. Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives. In: Scatena R, editor. Advances in Cancer Biomarkers. Dordrecht: Springer Netherlands; 2015. pp. 9-26. [DOI: 10.1007/978-94-017-7215-0_2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ye F, Zhao Y, El-sayed R, Muhammed M, Hassan M. Advances in nanotechnology for cancer biomarkers. Nano Today 2018;18:103-23. [DOI: 10.1016/j.nantod.2017.12.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 9.3] [Reference Citation Analysis]
2 Boniolo G, Campaner R. Complexity and integration. A philosophical analysis of how cancer complexity can be faced in the era of precision medicine. Euro Jnl Phil Sci 2019;9. [DOI: 10.1007/s13194-019-0257-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Li Q, Chen P, Yang H, Luo M, You W, Zhao P. Synthesis, antiproliferative evaluation, and structure–activity relationships of novel triazole–isoindoline hybrids bearing 3,4,5-trimethoxyphenyl moiety. Chem Pap 2018;72:651-9. [DOI: 10.1007/s11696-017-0311-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Wang Y, Sun M, Liu J, Liu Y, Jiang C, Zhu H, Wang W, Wang Y. FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma. Oncol Lett 2020;19:795-804. [PMID: 31897196 DOI: 10.3892/ol.2019.11183] [Reference Citation Analysis]
5 Falanga A, Marchetti M. Hemostatic biomarkers in cancer progression. Thromb Res 2018;164 Suppl 1:S54-61. [PMID: 29703485 DOI: 10.1016/j.thromres.2018.01.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
6 Jiang C, Zhu J, Zhou P, Zhu H, Wang W, Jin Q, Li P. Overexpression of FIBCD1 is predictive of poor prognosis in gastric cancer. Am J Clin Pathol. 2018;149:474-83. [PMID: 29969699 DOI: 10.1093/ajcp/aqy013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ji X, Cui Q. Ancient genes can be served as pan-cancer diagnostic and prognostic biomarkers. J Cell Mol Med 2020;24:6908-15. [PMID: 32368859 DOI: 10.1111/jcmm.15347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
9 Rush A, Matzke L, Cooper S, Gedye C, Byrne JA, Watson PH. Research Perspective on Utilizing and Valuing Tumor Biobanks. Biopreservation and Biobanking 2019;17:219-29. [DOI: 10.1089/bio.2018.0099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
10 Kohler I, Verhoeven A, Derks RJ, Giera M. Analytical pitfalls and challenges in clinical metabolomics. Bioanalysis 2016;8:1509-32. [DOI: 10.4155/bio-2016-0090] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
11 Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, Pomper MG, Fisher PB. Detecting Tumor Metastases: The Road to Therapy Starts Here. Adv Cancer Res 2016;132:1-44. [PMID: 27613128 DOI: 10.1016/bs.acr.2016.07.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
12 Zhang J, Chua SL, Khoo BL. Worm-Based Microfluidic Biosensor for Real-Time Assessment of the Metastatic Status. Cancers (Basel) 2021;13:873. [PMID: 33669617 DOI: 10.3390/cancers13040873] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Martínez-García C, Medina-Flores Y, de la Rosa-Vázquez JM, Soriano-Pérez EE, Villalobos-Hernández JR, Ramón-Gallegos E. Theranostic-PDT with the antibody anti isoform 4 SOD mitocondrial labeled with PpIX in the lung cancer cell line A-549. Photodiagnosis Photodyn Ther 2018;22:197-204. [PMID: 29601905 DOI: 10.1016/j.pdpdt.2018.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Balis FM, Busch CM, Desai AV, Hibbitts E, Naranjo A, Bagatell R, Irwin M, Fox E. The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma. Pediatr Blood Cancer 2020;67:e28031. [PMID: 31612589 DOI: 10.1002/pbc.28031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
15 Alarfaj NA, El-Tohamy MF, Oraby HF. CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite. Int J Mol Sci 2018;19:E1162. [PMID: 29641488 DOI: 10.3390/ijms19041162] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 8.8] [Reference Citation Analysis]
16 Hussein AA, Forouzanfar T, Bloemena E, de Visscher J, Brakenhoff RH, Leemans CR, Helder MN. A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma. Br J Cancer 2018;119:724-36. [PMID: 30131545 DOI: 10.1038/s41416-018-0233-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
17 Jing W, Wang Y, Yang Y, Wang Y, Ma G, Wang S, Tao N. Time-Resolved Digital Immunoassay for Rapid and Sensitive Quantitation of Procalcitonin with Plasmonic Imaging. ACS Nano 2019;13:8609-17. [PMID: 31276361 DOI: 10.1021/acsnano.9b02771] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 10.7] [Reference Citation Analysis]
18 Yang J, Li D, Wang J, Zhang R, Li J. Design, optimization, and application of multiplex rRT-PCR in the detection of respiratory viruses. Crit Rev Clin Lab Sci 2022;:1-18. [PMID: 35559711 DOI: 10.1080/10408363.2022.2072467] [Reference Citation Analysis]
19 Rodríguez-Lescure A, de la Peña FA, Aranda E, Calvo A, Felip E, Garrido P, Vera R. Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain. Clin Transl Oncol 2020;22:2253-63. [PMID: 32533318 DOI: 10.1007/s12094-020-02366-y] [Reference Citation Analysis]
20 Jiang D, Zhang X, Liu M, Wang Y, Wang T, Pei L, Wang P, Ye H, Shi J, Song C, Wang K, Wang X, Dai L, Zhang J. Discovering Panel of Autoantibodies for Early Detection of Lung Cancer Based on Focused Protein Array. Front Immunol 2021;12:658922. [PMID: 33968062 DOI: 10.3389/fimmu.2021.658922] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Martins D, Spada F, Lambrescu I, Rubino M, Cella C, Gibelli B, Grana C, Ribero D, Bertani E, Ravizza D, Bonomo G, Funicelli L, Pisa E, Zerini D, Fazio N; IEO ENETS Center of Excellence for GEP NETs. Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors. Target Oncol 2017;12:611-22. [PMID: 28634872 DOI: 10.1007/s11523-017-0506-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
22 Dos Santos ES, Ramos JC, Roza ALOC, Mariz BALA, Paes Leme AF. The role of osteopontin in oral cancer: A brief review with emphasis on clinical applications. Oral Dis 2020. [PMID: 33188646 DOI: 10.1111/odi.13716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Yuan M, Breitkopf SB, Asara JM. Serial-omics characterization of equine urine. PLoS One 2017;12:e0186258. [PMID: 29028822 DOI: 10.1371/journal.pone.0186258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Špilak A, Brachner A, Kegler U, Neuhaus W, Noehammer C. Implications and pitfalls for cancer diagnostics exploiting extracellular vesicles. Adv Drug Deliv Rev 2021;175:113819. [PMID: 34087328 DOI: 10.1016/j.addr.2021.05.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Caputo D, Caracciolo G. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma. Cancer Lett. 2020;470:191-196. [PMID: 31783084 DOI: 10.1016/j.canlet.2019.11.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
26 Khalil-Mgharbel A, Polena H, Dembélé PK, Hasan Sohag MM, Alcaraz JP, Martin DK, Vilgrain I. A Biomimetic Lipid Membrane Device Reveals the Interaction of Cancer Biomarkers with Human Serum Lipidic Moieties. Biotechnol J 2018;13:e1800463. [PMID: 30457706 DOI: 10.1002/biot.201800463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
27 Ferreira CG, Nicolini A, Dalurzo L, Stefani S, Teich V, Leighl N. The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy. CDT 2018;20:81-6. [DOI: 10.2174/1389450119666180911093143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Baker MJ, Byrne HJ, Chalmers J, Gardner P, Goodacre R, Henderson A, Kazarian SG, Martin FL, Moger J, Stone N, Sulé-suso J. Clinical applications of infrared and Raman spectroscopy: state of play and future challenges. Analyst 2018;143:1735-57. [DOI: 10.1039/c7an01871a] [Cited by in Crossref: 97] [Cited by in F6Publishing: 32] [Article Influence: 24.3] [Reference Citation Analysis]
29 Ribeiro JA, Sales MGF, Pereira CM. Electrochemistry-Assisted Surface Plasmon Resonance Biosensor for Detection of CA 15-3. Anal Chem 2021;93:7815-24. [PMID: 34038085 DOI: 10.1021/acs.analchem.0c05367] [Reference Citation Analysis]
30 Bertok T, Lorencova L, Chocholova E, Jane E, Vikartovska A, Kasak P, Tkac J. Electrochemical Impedance Spectroscopy Based Biosensors: Mechanistic Principles, Analytical Examples and Challenges towards Commercialization for Assays of Protein Cancer Biomarkers. ChemElectroChem 2019;6:989-1003. [DOI: 10.1002/celc.201800848] [Cited by in Crossref: 55] [Cited by in F6Publishing: 17] [Article Influence: 13.8] [Reference Citation Analysis]
31 Lee CH, Hung PF, Lu SC, Chung HL, Chiang SL, Wu CT, Chou WC, Sun CY. MCP-1/MCPIP-1 Signaling Modulates the Effects of IL-1β in Renal Cell Carcinoma through ER Stress-Mediated Apoptosis. Int J Mol Sci 2019;20:E6101. [PMID: 31816951 DOI: 10.3390/ijms20236101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]